These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
171 related articles for article (PubMed ID: 36595296)
1. Examination of Adverse Reactions After COVID-19 Vaccination Among Patients With a History of Multisystem Inflammatory Syndrome in Children. Elias MD; Truong DT; Oster ME; Trachtenberg FL; Mu X; Jone PN; Mitchell EC; Dummer KB; Sexson Tejtel SK; Osakwe O; Thacker D; Su JA; Bradford TT; Burns KM; Campbell MJ; Connors TJ; D'Addese L; Forsha D; Frosch OH; Giglia TM; Goodell LR; Handler SS; Hasbani K; Hebson C; Krishnan A; Lang SM; McCrindle BW; McHugh KE; Morgan LM; Payne RM; Sabati A; Sagiv E; Sanil Y; Serrano F; Newburger JW; Dionne A; JAMA Netw Open; 2023 Jan; 6(1):e2248987. PubMed ID: 36595296 [TBL] [Abstract][Full Text] [Related]
2. Reported cases of multisystem inflammatory syndrome in children aged 12-20 years in the USA who received a COVID-19 vaccine, December, 2020, through August, 2021: a surveillance investigation. Yousaf AR; Cortese MM; Taylor AW; Broder KR; Oster ME; Wong JM; Guh AY; McCormick DW; Kamidani S; Schlaudecker EP; Edwards KM; Creech CB; Staat MA; Belay ED; Marquez P; Su JR; Salzman MB; Thompson D; Campbell AP; Lancet Child Adolesc Health; 2022 May; 6(5):303-312. PubMed ID: 35216660 [TBL] [Abstract][Full Text] [Related]
3. Incidence of Guillain-Barré Syndrome After COVID-19 Vaccination in the Vaccine Safety Datalink. Hanson KE; Goddard K; Lewis N; Fireman B; Myers TR; Bakshi N; Weintraub E; Donahue JG; Nelson JC; Xu S; Glanz JM; Williams JTB; Alpern JD; Klein NP JAMA Netw Open; 2022 Apr; 5(4):e228879. PubMed ID: 35471572 [TBL] [Abstract][Full Text] [Related]
4. Evaluation of Autoantibody Binding to Cardiac Tissue in Multisystem Inflammatory Syndrome in Children and COVID-19 Vaccination-Induced Myocarditis. Patel H; Sintou A; Chowdhury RA; Rothery S; Iacob AO; Prasad S; Rainer PP; Martinón-Torres F; Sancho-Shimizu V; Shimizu C; Dummer K; Tremoulet AH; Burns JC; Sattler S; Levin M; JAMA Netw Open; 2023 May; 6(5):e2314291. PubMed ID: 37200028 [TBL] [Abstract][Full Text] [Related]
5. Tolerability of COVID-19 Infection and Messenger RNA Vaccination Among Patients With a History of Kawasaki Disease. Beckley M; Olson AK; Portman MA JAMA Netw Open; 2022 Aug; 5(8):e2226236. PubMed ID: 35960521 [TBL] [Abstract][Full Text] [Related]
6. A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trial. Akova M; Unal S Trials; 2021 Apr; 22(1):276. PubMed ID: 33849629 [TBL] [Abstract][Full Text] [Related]
7. Reports of Guillain-Barré Syndrome After COVID-19 Vaccination in the United States. Abara WE; Gee J; Marquez P; Woo J; Myers TR; DeSantis A; Baumblatt JAG; Woo EJ; Thompson D; Nair N; Su JR; Shimabukuro TT; Shay DK JAMA Netw Open; 2023 Feb; 6(2):e2253845. PubMed ID: 36723942 [TBL] [Abstract][Full Text] [Related]
8. Surveillance of Safety of 3 Doses of COVID-19 mRNA Vaccination Using Electronic Health Records. Niesen MJM; Pawlowski C; O'Horo JC; Challener DW; Silvert E; Donadio G; Lenehan PJ; Virk A; Swift MD; Speicher LL; Gordon JE; Geyer HL; Halamka JD; Venkatakrishnan AJ; Soundararajan V; Badley AD JAMA Netw Open; 2022 Apr; 5(4):e227038. PubMed ID: 35420661 [TBL] [Abstract][Full Text] [Related]
9. Complications, Adverse Drug Events, High Costs, and Disparities in Multisystem Inflammatory Syndrome in Children vs COVID-19. Encinosa W; Moon K; Figueroa J; Elias Y JAMA Netw Open; 2023 Jan; 6(1):e2244975. PubMed ID: 36602804 [TBL] [Abstract][Full Text] [Related]
10. Myocarditis Following Immunization With mRNA COVID-19 Vaccines in Members of the US Military. Montgomery J; Ryan M; Engler R; Hoffman D; McClenathan B; Collins L; Loran D; Hrncir D; Herring K; Platzer M; Adams N; Sanou A; Cooper LT JAMA Cardiol; 2021 Oct; 6(10):1202-1206. PubMed ID: 34185045 [TBL] [Abstract][Full Text] [Related]
11. Multisystem Inflammatory Syndrome in Adults After Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection and Coronavirus Disease 2019 (COVID-19) Vaccination. Belay ED; Godfred Cato S; Rao AK; Abrams J; Wilson WW; Lim S; Newton-Cheh C; Melgar M; DeCuir J; Webb B; Marquez P; Su JR; Meng L; Grome HN; Schlaudecker E; Talaat K; Edwards K; Barnett E; Campbell AP; Broder KR; Bamrah Morris S Clin Infect Dis; 2022 Aug; 75(1):e741-e748. PubMed ID: 34849680 [TBL] [Abstract][Full Text] [Related]
12. COVID-19 Vaccine Reactogenicity and Vaccine Attitudes Among Children and Parents/Guardians After Multisystem Inflammatory Syndrome in Children or COVID-19 Hospitalization: September 2021-May 2022. Yousaf AR; Kunkel A; Abrams JY; Shah AB; Hammett TA; Arnold KE; Beltran YL; Laham FR; Kao CM; Hunstad DA; Hussaini L; Baida N; Salazar L; Perez MA; Rostad CA; Godfred-Cato S; Campbell AP; Belay ED Pediatr Infect Dis J; 2023 Mar; 42(3):252-259. PubMed ID: 36729032 [TBL] [Abstract][Full Text] [Related]
13. Safety of the BNT162b2 COVID-19 Vaccine in Children Aged 5 to 17 Years. Hu M; Wong HL; Feng Y; Lloyd PC; Smith ER; Amend KL; Kline A; Beachler DC; Gruber JF; Mitra M; Seeger JD; Harris C; Secora A; Obidi J; Wang J; Song J; McMahill-Walraven CN; Reich C; McEvoy R; Do R; Chillarige Y; Clifford R; Cooper DD; Shoaibi A; Forshee R; Anderson SA JAMA Pediatr; 2023 Jul; 177(7):710-717. PubMed ID: 37213095 [TBL] [Abstract][Full Text] [Related]
14. COVID-19 Vaccination Coverage and Demographic Characteristics of Infants and Children Aged 6 Months-4 Years - United States, June 20-December 31, 2022. Murthy BP; Fast HE; Zell E; Murthy N; Meng L; Shaw L; Vogt T; Chatham-Stephens K; Santibanez TA; Gibbs-Scharf L; Harris LQ MMWR Morb Mortal Wkly Rep; 2023 Feb; 72(7):183-189. PubMed ID: 36795658 [TBL] [Abstract][Full Text] [Related]
16. The short term safety of COVID-19 vaccines in Australia: AusVaxSafety active surveillance, February - August 2021. Deng L; Glover C; Dymock M; Pillsbury A; Marsh JA; Quinn HE; Leeb A; Cashman P; Snelling TL; Wood N; Macartney K Med J Aust; 2022 Aug; 217(4):195-202. PubMed ID: 35781813 [TBL] [Abstract][Full Text] [Related]
17. BNT162b2 mRNA Vaccination Against Coronavirus Disease 2019 is Associated With a Decreased Likelihood of Multisystem Inflammatory Syndrome in Children Aged 5-18 Years-United States, July 2021 - April 2022. Zambrano LD; Newhams MM; Olson SM; Halasa NB; Price AM; Orzel AO; Young CC; Boom JA; Sahni LC; Maddux AB; Bline KE; Kamidani S; Tarquinio KM; Chiotos K; Schuster JE; Cullimore ML; Heidemann SM; Hobbs CV; Nofziger RA; Pannaraj PS; Cameron MA; Walker TC; Schwartz SP; Michelson KN; Coates BM; Flori HR; Mack EH; Smallcomb L; Gertz SJ; Bhumbra SS; Bradford TT; Levy ER; Kong M; Irby K; Cvijanovich NZ; Zinter MS; Bowens C; Crandall H; Hume JR; Patel MM; Campbell AP; Randolph AG; Clin Infect Dis; 2023 Feb; 76(3):e90-e100. PubMed ID: 35924406 [TBL] [Abstract][Full Text] [Related]
18. Risk of adverse events after covid-19 in Danish children and adolescents and effectiveness of BNT162b2 in adolescents: cohort study. Kildegaard H; Lund LC; Højlund M; Stensballe LG; Pottegård A BMJ; 2022 Apr; 377():e068898. PubMed ID: 35410884 [TBL] [Abstract][Full Text] [Related]
19. Incidence of Multisystem Inflammatory Syndrome in Children Among US Persons Infected With SARS-CoV-2. Payne AB; Gilani Z; Godfred-Cato S; Belay ED; Feldstein LR; Patel MM; Randolph AG; Newhams M; Thomas D; Magleby R; Hsu K; Burns M; Dufort E; Maxted A; Pietrowski M; Longenberger A; Bidol S; Henderson J; Sosa L; Edmundson A; Tobin-D'Angelo M; Edison L; Heidemann S; Singh AR; Giuliano JS; Kleinman LC; Tarquinio KM; Walsh RF; Fitzgerald JC; Clouser KN; Gertz SJ; Carroll RW; Carroll CL; Hoots BE; Reed C; Dahlgren FS; Oster ME; Pierce TJ; Curns AT; Langley GE; Campbell AP; ; Balachandran N; Murray TS; Burkholder C; Brancard T; Lifshitz J; Leach D; Charpie I; Tice C; Coffin SE; Perella D; Jones K; Marohn KL; Yager PH; Fernandes ND; Flori HR; Koncicki ML; Walker KS; Di Pentima MC; Li S; Horwitz SM; Gaur S; Coffey DC; Harwayne-Gidansky I; Hymes SR; Thomas NJ; Ackerman KG; Cholette JM JAMA Netw Open; 2021 Jun; 4(6):e2116420. PubMed ID: 34110391 [TBL] [Abstract][Full Text] [Related]
20. Comparative Risks of Potential Adverse Events Following COVID-19 mRNA Vaccination Among Older US Adults. Harris DA; Hayes KN; Zullo AR; Mor V; Chachlani P; Deng Y; McCarthy EP; Djibo DA; McMahill-Walraven CN; Gravenstein S JAMA Netw Open; 2023 Aug; 6(8):e2326852. PubMed ID: 37531110 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]